Sign Up to like & get
recommendations!
0
Published in 2017 at "Drugs"
DOI: 10.1007/s40265-017-0780-7
Abstract: Abaloparatide (Tymlos™) is a synthetic peptide analogue of human parathyroid hormone-related protein that was developed by Radius Health as an osteoanabolic agent for the treatment of postmenopausal osteoporosis. Abaloparatide acts through selective activation of the…
read more here.
Keywords:
abaloparatide first;
global approval;
treatment postmenopausal;
first global ... See more keywords